1. Home
  2. CMCM vs ACIU Comparison

CMCM vs ACIU Comparison

Compare CMCM & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Mobile Inc. each representing fifty (50)

CMCM

Cheetah Mobile Inc. each representing fifty (50)

HOLD

Current Price

$6.99

Market Cap

199.5M

Sector

Technology

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.56

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCM
ACIU
Founded
2009
2003
Country
China
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.5M
213.3M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
CMCM
ACIU
Price
$6.99
$3.56
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
18.8K
444.5K
Earning Date
11-26-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$151,517,306.00
$5,482,957.00
Revenue This Year
$14.27
N/A
Revenue Next Year
$39.26
$644.42
P/E Ratio
N/A
N/A
Revenue Growth
46.34
N/A
52 Week Low
$3.28
$1.43
52 Week High
$9.44
$4.00

Technical Indicators

Market Signals
Indicator
CMCM
ACIU
Relative Strength Index (RSI) 54.97 56.14
Support Level $6.29 $3.32
Resistance Level $7.20 $3.74
Average True Range (ATR) 0.28 0.22
MACD 0.10 0.03
Stochastic Oscillator 79.86 66.67

Price Performance

Historical Comparison
CMCM
ACIU

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: